Results 11 to 20 of about 81,528 (247)

Epidemiology of urticaria in China: a population-based study

Chinese Medical Journal, 2022
. Background:. Urticaria is a common skin disease characterized by episodes of wheals, and it has a negative effect on patients’ quality of life. Large-scale population-based epidemiological studies of urticaria are scarce in China.
Jiaqing Li, Dandan Mao, Shuoshuo Liu, Ping Liu, Jing Tian, Chenhong Xue, Xiaojing Liu, Ruiqun Qi, Bingxue Bai, Jianjun Nie, Siqi Ye, Yu Wang, Yuye Li, Qing Sun, Juan Tao, Shuping Guo, Hong Fang, Jianqin Wang, Qiri Mu, Quanzhong Liu, Yan Ding, Jianzhong Zhang, Lishao Guo   +22 more
doaj   +2 more sources

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Allergy. European Journal of Allergy and Clinical Immunology, 2021
This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of
T. Zuberbier, A. A. Abdul Latiff, M. Abuzakouk, S. Aquilina, R. Asero, D. Baker, B. Ballmer-Weber, C. Bangert, M. Ben-Shoshan, J. Bernstein, C. Bindslev‐Jensen, K. Brockow, Z. Brzoza, H. C. Chong Neto, M. Church, P. Criado, I. Danilycheva, C. Dressler, L. Ensina, L. Fonacier, M. Gaskins, K. Gáspár, A. Gelincik, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, M. Grosber, E. Hamelmann, J. Hébert, M. Hide, A. Kaplan, A. Kapp, A. Kessel, E. Kocatürk, K. Kulthanan, D. Larenas-Linnemann, A. Lauerma, T. Leslie, M. Magerl, M. Makris, R. Meshkova, M. Metz, D. Micallef, C. Mortz, A. Nast, H. Oude-Elberink, R. Pawankar, P. Pigatto, H. R. Ratti Sisa, M. I. Rojo Gutiérrez, S. Saini, P. Schmid‐Grendelmeier, B. Sekerel, F. Siebenhaar, H. Siiskonen, A. Soria, P. Staubach‐Renz, L. Stingeni, G. Sussman, A. Szegedi, S. Thomsen, Z. Vadasz, C. Vestergaard, B. Wedi, Zuotao Zhao, M. Maurer   +66 more
semanticscholar   +1 more source

Chronic urticaria and the pathogenic role of mast cells.

Allergology International, 2023
The signs and symptoms of chronic urticaria (CU) are caused by the activation and degranulation of skin mast cells (MCs). Recent studies have added to our understanding of how and why skin MCs are involved and different in CU.
D. Elieh-Ali-Komi, M. Metz, P. Kolkhir, Emek Kocatürk, J. Scheffel, Stefan Frischbutter, D. Terhorst‐Molawi, Lena Fox, M. Maurer   +8 more
semanticscholar   +1 more source

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.

Journal of Allergy and Clinical Immunology, 2022
BACKGROUND Chronic spontaneous urticaria is inadequately controlled in many patients and severely impacts the quality of life. Remibrutinib, a highly selective, oral, novel covalent Bruton's tyrosine kinase inhibitor, might be effective in chronic ...
M. Maurer, W. Berger, A. Giménez-Arnau, K. Hayama, V. Jain, A. Reich, S. Haemmerle, K. Lheritier, P. Walsh, S. Xia, J. Storim   +10 more
semanticscholar   +1 more source

Predictors of treatment response in chronic spontaneous urticaria

Allergy. European Journal of Allergy and Clinical Immunology, 2021
The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the international guideline, entails treatment escalation from second‐generation H1‐antihistamines (sgAHs) to omalizumab and cyclosporine until complete response is ...
J. Fok, P. Kolkhir, M. Church, M. Maurer
semanticscholar   +1 more source

The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells.

Journal of Allergy and Clinical Immunology: In Practice, 2021
Chronic spontaneous urticaria is characterized by a perivascular non-necrotizing cellular infiltrate around small venules of the skin. It consists primarily of CD4(+) lymphocytes, a prominence of the Th-2 subtype but also Th-1 cells, with Th 17 cell ...
A. Giménez-Arnau, Laurence DeMontojoye, R. Asero, M. Cugno, K. Kulthanan, Y. Yanase, M. Hide, A. Kaplan   +7 more
semanticscholar   +1 more source

Total IgE as a Marker for Chronic Spontaneous Urticaria

Allergy Asthma and Immunology Research, 2021
Objective Immunoglobulin E (IgE) and its receptor, FcɛRI, importantly contribute to the pathophysiology of chronic spontaneous urticaria (CSU). Recent findings point to a possible role of total IgE as a marker of CSU disease activity, endotypes, and ...
S. Altrichter, J. Fok, Q. Jiao, P. Kolkhir, P. Pyatilova, S. Romero, J. Scheffel, F. Siebenhaar, Carolin Steinert, D. Terhorst‐Molawi, Y. Xiang, M. Church, M. Maurer   +12 more
semanticscholar   +1 more source

Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis

Allergy. European Journal of Allergy and Clinical Immunology, 2020
Urticaria is a frequent skin condition, but reliable prevalence estimates from population studies particularly of the chronic form are scarce. The objective of this study was to systematically evaluate and summarize the prevalence of chronic urticaria by
J. Fricke, Gabriela Ávila, T. Keller, K. Weller, S. Lau, M. Maurer, T. Zuberbier, T. Keil   +7 more
semanticscholar   +1 more source

The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management☆

The World Allergy Organization Journal, 2021
This is Part 1 of an updated follow-up review of a World Allergy Organization (WAO) position paper published in 2012 on the diagnosis and treatment of urticaria and angioedema. Since 2012, there have been advances in the understanding of the pathogenesis
M. Sánchez-Borges, I. Ansotegui, I. Baiardini, J. Bernstein, G. Canonica, M. Ebisawa, Maximiliano R Gómez, S. González-Díaz, Bryan L. Martin, M. Morais‐Almeida, J. O. Ortega Martell   +10 more
semanticscholar   +1 more source

The global burden of chronic urticaria for the patient and society *

British Journal of Dermatology, 2020
Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle‐aged women. It usually lasts for several years (> 1 year in 25–75% of patients) and often takes > 1 year before effective management is implemented.
M. Gonçalo, A. Giménez-Arnau, M. Al‐Ahmad, M. Ben-Shoshan, J. Bernstein, L. Ensina, D. Fomina, D. Fomina, C. Galván, K. Godse, C. Grattan, M. Hide, C. Katelaris, M. Khoshkhui, E. Kocatürk, K. Kulthanan, I. Medina, I. Nasr, J. Peter, P. Staubach, L. Wang, K. Weller, Marcus Maurer   +22 more
semanticscholar   +1 more source